clinical trial · NCT07264413
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
Cardiovascular and Interventional Radiological Society of Europe·—·not yet recruiting·n = 250
HemorrhoidHemorrhoid BleedingHaemorrhoid artery embolizsation (HAE)
brief summary
BRIGHT is a Europe-wide study that will follow up to 250 adults with bleeding symptoms from haemmorhoids (Grade II-III categories). It aims to understand how well a minimally invasive procedure called haemorrhoid artery embolization (HAE) works in everyday clinical practice, which is a technique that blocks the blood vessels feeding the haemorrhoids. As this technique does not require major surgery, HAE offers several benefits such as less trauma, quicker recovery, and the use of only local anaesthesia.
started
Apr 1, 2026
primary completion
Apr 1, 2030
completion
Dec 1, 2030
last updated
Dec 4, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol